Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function - Wikidata - awgldk - TriplyDB

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

http://www.wikidata.org/entity/Q36378477

about

Epigenetic associations in relation to cardiovascular prevention and therapeutics Role of redoximiRs in fibrogenesis MicroRNAs in the Stressed Heart: Sorting the Signal from the Noise Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease Cross talk between spliceosome and microprocessor defines the fate of pre-mRNA Vinculin network-mediated cytoskeletal remodeling regulates contractile function in the aging heart Using microRNA as an alternative treatment for hyperlipidemia and cardiovascular disease: cardio-miRs in the pipeline Regulatory non-coding RNAs in acute myocardial infarction Developing miRNA therapeutics for cardiac repair in ischemic heart disease New Treatment Strategies for Alcohol-Induced Heart Damage MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4 miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction miR-1231 exacerbates arrhythmia by targeting calciumchannel gene CACNA2D2 in myocardial infarction The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1 Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium Development of microRNA therapeutics is coming of age.Adult-specific functions of animal microRNAs.The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity Nonconventional chemical inhibitors of microRNA: therapeutic scope.Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-β Pathway.MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.MicroRNAs and cardiovascular medicine Alteration of Aging-Dependent MicroRNAs in Idiopathic Pulmonary Fibrosis.Identification of targets of tumor suppressor microRNA-34a using a reporter library system Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs.MicroRNAs in vascular tissue engineering and post-ischemic neovascularization MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload

P2860

Q26771428-50EDB93C-B2C0-4766-977F-259021AF0F3D Q26776555-E7380CFE-0131-409D-8A93-1FDC1750598C Q26995334-F05365E9-60A1-4B46-B807-B77BD5E9DC1D Q26999363-D28BB507-07A8-44AB-89CC-551A7F3BBDC9 Q27013994-07ACFE73-1FA1-4E98-B923-F0C6C81BC6D9 Q27325632-1CB9B389-8C59-4B00-86BE-621E4D5C3D4A Q27694686-FF8822C9-3AC7-42C0-98A7-CC05F6D766EC Q28077279-565624D0-5E65-462D-968C-56CC5F9FE4BA Q28077986-6D411E11-BB52-434C-ABE0-1EE5BAE3CFAD Q28078093-54B29CD1-583C-4BC7-8535-E3C47A92E0DC Q28118775-AAFF24EC-5AEA-4183-ABBE-06CD88923935 Q28544014-BA9CDB19-970A-4BB2-82CF-B9018C04F2FE Q28583018-FFFECAED-0703-42F6-B460-C2AAC1B766D2 Q28975627-ACB08210-5445-458E-9E9D-C437EAEF706B Q33580495-3ADB0D20-F8F6-46AA-85B9-526F8BB8FCE3 Q33623149-3EDD6F3A-5FC9-40D9-BE07-10E5BA3B18FC Q33624461-AE9AA1FB-ED5D-49F3-BB7D-E58217CC6374 Q33661920-4F954B49-BD41-4F34-946F-157301B02601 Q33688416-D5B7A470-FD6F-4B3C-A43B-52DDA59B4492 Q33753317-424369FE-6D07-47C4-AEBE-F982F31850E7 Q33807788-E07DA659-B7D3-4D5E-888C-3BF4DAA5F5E9 Q33865102-121F0833-B164-4146-B612-E8B7F68562F8 Q33889242-AB119314-A37A-4D66-877B-35963408CF8B Q33991443-AD6EBB2A-2A0F-4E9A-BBCF-4491150143D5 Q34061489-6424B74D-66EA-4C97-AC8D-69F09AC385B1 Q34356918-7BA730DD-E7C0-46CB-9E6F-EC12A82AD2AE Q35057730-1AF8F50D-84DE-44D7-9E0F-BC99EADB9725 Q35108974-B408BBA8-487D-4D0D-A459-0CA7550000F7 Q35146756-2CAB9A61-FAE4-4716-9431-1B49DC3DBAA6 Q35346350-109E6799-143D-4FCC-92BE-727E4EA7D3AC Q35610932-3E18E9F5-5134-44D8-85C6-5038D1B968AF Q35836093-81473D44-9052-478B-BF55-B664FCD3B8B6 Q36135052-496734B8-E34A-4066-B607-90C4DFD53656 Q36165889-FA5A8F3A-D30C-4248-84C2-7EC117BF0C84 Q36190899-35465138-1AEC-41A1-A830-B3720296A823 Q36327495-77F3D678-1A96-4AC3-B054-08CA58DCEDAC Q36378208-FD05AABE-AC73-4FFE-A7B5-0660CE99ADA9 Q36506217-AD125631-3995-4121-A09E-1026F50D37D2 Q36626642-563E7034-BDB9-463C-A7D8-32E25D0DF75B Q36634367-ADE43470-83D9-4DE9-8DFE-065B2071F9F6

P2860

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

http://www.wikidata.org/entity/Q36378477

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Therapeutic inhibition of the ...... ng and improves heart function

@ast

Therapeutic inhibition of the ...... ng and improves heart function

@en

type

label

Therapeutic inhibition of the ...... ng and improves heart function

@ast

Therapeutic inhibition of the ...... ng and improves heart function

@en

prefLabel

Therapeutic inhibition of the ...... ng and improves heart function

@ast

Therapeutic inhibition of the ...... ng and improves heart function

@en

P1433

Q36378477-C14731D2-155D-47BF-92AE-95A739F75906

P1476

Q36378477-DAAD6047-7D4C-4C64-A870-661BB829FBB5

P2093

Q36378477-1E79D7F3-0323-47D1-8CFB-7305A5187066

Q36378477-2D578B37-6911-4E8D-8C47-0B30C11644C3

Q36378477-42712D3C-AB55-4941-935F-42D248D1964B

Q36378477-48897827-77A7-4278-AA46-DC6455DF91C3

Q36378477-5AF335A1-BDFB-46B4-B43D-FA7D1C99C521

Q36378477-627EA728-BAB7-4C11-BEC7-936C0694143C

Q36378477-9E2BD1CA-9095-4F2E-B24F-DB7445BDFD96

Q36378477-E7F81126-8EA5-400A-8476-40682F3E5571

Q36378477-F0C3EBF2-CAF3-43BF-8971-50FC36DC84C5

P2860

Q36378477-03FCA103-2524-4833-B067-FAB48914825A

Q36378477-0C4B0C07-2DAF-47B1-8A87-ACA4E0A00218

Q36378477-0F014E48-ABDD-445F-8442-E7485D7B232A

Q36378477-15BB8B7A-50E4-4C18-8196-96B102CB9EFF

Q36378477-188A0885-59F8-437B-A689-28A717CBAF91

Q36378477-2427A9D5-711B-4D7B-A4A0-763844081DDC

Q36378477-2ED29C20-6EFA-4CA6-8276-B2129B9A41B4

Q36378477-3712AE4B-5AF9-4DD9-BE8E-EC00EEEC463A

Q36378477-37E36CC7-12E6-408E-A8AA-F3C7ED892147

Q36378477-3CDF9590-08A5-40EB-B673-7D7623E0C51F

P304

Q36378477-A5242A77-5A11-4F71-8FE9-14FD3CDCDF2D

P31

Q36378477-E662B8E8-99DD-4CCD-B0F1-2038242850BB

P356

Q36378477-17B831DF-2CAE-479B-9B7A-4071E6C3097E

P407

Q36378477-30E27049-128F-4903-A4B5-259E21D495D3

P433

Q36378477-CC6CAE1E-44F8-4625-A007-6B14EC9D371A

P478

Q36378477-1997E900-F92A-45FB-9ED2-EC7E5EC76677

P50

Q36378477-1AE727F1-9647-461D-8445-62DC53B027BB

Q36378477-449437F8-F1A0-4B18-933B-8852E10795C0

Q36378477-A717A2C4-BE9F-4ED2-9C50-B953FC88B0C1

P577

Q36378477-ACD61876-DF0B-4D7E-8EE7-68C5694A62E2

P5875

Q36378477-74507442-BF8B-4896-841F-36752FA1F73D

P698

Q36378477-9664EF83-3C88-48AD-9ABE-7ED9E9F060FB

P921

Q36378477-E9941415-FC3C-4099-A1EB-FD6D8EF2C9C8

P932

Q36378477-76E8053B-523D-4F9E-A5E1-4070E13DAD50

P356

PNAS.1206432109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Therapeutic inhibition of the ...... ng and improves heart function

@en

P2093

Catherine E Winbanks

http://www.w3.org/2001/XMLSchema#string

Esther J H Boey

http://www.w3.org/2001/XMLSchema#string

Helen Kiriazis

http://www.w3.org/2001/XMLSchema#string

Julie R McMullen

http://www.w3.org/2001/XMLSchema#string

Ruby C Y Lin

http://www.w3.org/2001/XMLSchema#string

Sakari Kauppinen

http://www.w3.org/2001/XMLSchema#string

Susanna Obad

http://www.w3.org/2001/XMLSchema#string

Xiao-Jun Du

http://www.w3.org/2001/XMLSchema#string

Xiao-Ming Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of microRNA function by antimiR oligonucleotides

The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation

MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes

MicroRNA dysregulation in diabetic ischemic heart failure patients

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

Silencing of microRNAs in vivo with 'antagomirs'

Surfing the p53 network

Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells

LNA-mediated microRNA silencing in non-human primates

P304

17615-17620

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1206432109

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Bianca C. Bernardo

P577

2012-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232225682

http://www.w3.org/2001/XMLSchema#string

P698

23047694

http://www.w3.org/2001/XMLSchema#string

P921

P932

3491509

http://www.w3.org/2001/XMLSchema#string